CD44 Associates With EGFR and erbB2 in Metastasizing Mammary Carcinoma Cells
Manja Wobus, Reshma A. Rangwala, Irena Sheyn et al. · Applied immunohistochemistry & molecular morphology · 2002
Type I receptor tyrosine kinases, including the epidermal growth factor receptor (EGFR) and erbB2, have been implicated in mammary carcinoma growth and metastasis. Recent evidence suggests that type I receptor signaling may be mediated by the CD44 family of transmembrane glycoproteins that also have been implicated in mammary tumor progression. Here, the authors tested whether CD44, EGFR, and erbB2 interacted and colocalized with one another in four mammary carcinoma cell lines (MCF-7, MDA-MB-231, MDA-MB-435, and MDA-MB-436) and in cytology samples obtained from patients with metastatic breast cancer. CD44 constitutively colocalized and coimmunoprecipitated with erbB2 and EGFR in all four mammary carcinoma cell lines. CD44 also colocalized with erbB2 and EGFR in all cytology samples expressing erbB2. CD44 colocalized with EGFR in cells from only 1 of 16 erbB2-negative cytology samples. These data indicate that CD44-EGFR-erbB2 protein complexes occur in a high proportion of metastatic mammary carcinomas and suggest that CD44-type I receptor colocalization may be a novel prognostic marker for aggressive mammary cancers.
Cited by 61 works. doi:10.1097/00129039-200203000-00006
Authors
- Manja Wobus
- Reshma A. Rangwala
- Irena Sheyn
- Robert F. Hennigan
- Brigit Coila
- Elyse E. Lower
- Rawia S. Yassin
- Larry S. Sherman
References
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
- Prognostic Factors in Breast Cancer
- Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
- Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
- ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
- A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor
- Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
- Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
- Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.